Metabolism, Weight, Hormones, Microbiome
Dr. Noel Maclaren
Pioneering Endocrinologist, Internist, Pediatrician, Researcher & Entrepreneur
Dr. Noel Maclaren is a specialist endocrinologist - uniquely qualified as both internist and pediatrician specializing in general medicine, endocrinology and metabolism in adults and children. He has worked in NZ, Australia, London, Florida and is now based in New York. In addition to his specialist practice, he is scaling a bio-tech start-up, Metakura, with his co-founder Sunita Singh Maclaren, to democratize diagnostic and therapeutic expertise to address the biggest health challenges of the 21st C attributable to untreated metabolic imbalances: diabetes, childhood obesity, cardio-vascular and Alzheimer’s disease. As a researcher, he and his colleagues pioneered the use of antibody and genetic markers to identify those at risk for type-1 diabetes and endocrine disorders.
He convened the American Diabetes Association committee that first classified types of diabetes by their causes rather than their treatments.
Dr. Maclaren has authored over 50 medical book chapters on endocrine topics and published more than 300 peer-reviewed articles in international scientific journals.
He has won numerous awards and distinctions including Juvenile Diabetes Foundation International Award, David Rumbough Scientific Award, the International Canadian Diabetes Association/Connaught Novo Nordisk Award, Mary Jane Kugel Award for Diabetes Research from the Juvenile Diabetes Foundation. He was featured on the cover of France’s Paris-Match news weekly for his proposed diabetes vaccine. The Best Doctors Group ( Harvard University) has named him one of the Best Doctors in America and Best Doctors of New York.
More Advisory Board
Dr. Noel Maclaren is a specialist endocrinologist - uniquely qualified as both internist and pediatrician specializing in general medicine, endocrinology and metabolism in adults and children. He has worked in NZ, Australia, London, Florida and is now based in New York. In addition to his specialist practice, he is scaling a bio-tech start-up, Metakura, with his co-founder Sunita Singh Maclaren, to democratize diagnostic and therapeutic expertise to address the biggest health challenges of the 21st C attributable to untreated metabolic imbalances: diabetes, childhood obesity, cardio-vascular and Alzheimer’s disease. As a researcher, he and his colleagues pioneered the use of antibody and genetic markers to identify those at risk for type-1 diabetes and endocrine disorders.
He convened the American Diabetes Association committee that first classified types of diabetes by their causes rather than their treatments.
Dr. Maclaren has authored over 50 medical book chapters on endocrine topics and published more than 300 peer-reviewed articles in international scientific journals.
He has won numerous awards and distinctions including Juvenile Diabetes Foundation International Award, David Rumbough Scientific Award, the International Canadian Diabetes Association/Connaught Novo Nordisk Award, Mary Jane Kugel Award for Diabetes Research from the Juvenile Diabetes Foundation. He was featured on the cover of France’s Paris-Match news weekly for his proposed diabetes vaccine. The Best Doctors Group ( Harvard University) has named him one of the Best Doctors in America and Best Doctors of New York.
